Keywords: new, zometa, indication, filed, emea, novartis, submitted

New Zometa indication filed with EMEA

Article | 08 August 2001

Novartis has submitted a marketing authorization application to theEuropean Medicines Evaluation Agency for the bisphosphonate Zometa (zoledronic acid) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

zoledronic acid

Zometa

Aredia

Pamidronate Disodium

Go to drug listing